| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: DNA Viruses |
Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK1
Department of Virology, The Wright–Fleming Institute, Faculty of Medicine, Imperial College, St Mary’s Campus, Norfolk Place, London W2 1PG, UK2
Author for correspondence: Geoffrey Smith (at Imperial College). Fax +44 207 594 3973. e-mail glsmith{at}ic.ac.uk
The vaccinia virus (VV) N1L gene encodes a protein of 14 kDa that was identified previously in the concentrated supernatant of virus-infected cells. Here we show that the protein is present predominantly (>90%) within cells rather than in the culture supernatant and it exists as a non-glycosylated, non-covalent homodimer. The N1L protein present in the culture supernatant was uncleaved at the N terminus and was released from cells more slowly than the VV A41L gene product, a secreted glycoprotein that has a conventional signal peptide. Bioinformatic analyses predict that the N1L protein is largely alpha-helical and show that it is conserved in many VV strains, in other orthopoxviruses and in members of other chordopoxvirus genera. However, database searches found no non-poxvirus proteins with significant amino acid similarity to N1L. A deletion mutant lacking the N1L gene replicated normally in cell culture, but was attenuated in intranasal and intradermal murine models compared to wild-type and revertant controls. The conservation of the N1L protein and the attenuated phenotype of the deletion mutant indicate an important role in the virus life-cycle.
This article has been cited by other articles:
|
|
 |
|
  N. Jacobs, N. W. Bartlett, R. H. Clark, and G. L. Smith Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection J. Gen. Virol., November 1, 2008; 89(11): 2877 - 2881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Fahy, R. H. Clark, E. F. Glyde, and G. L. Smith Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence J. Gen. Virol., October 1, 2008; 89(10): 2377 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cooray, M. W. Bahar, N. G. A. Abrescia, C. E. McVey, N. W. Bartlett, R. A.-J. Chen, D. I. Stuart, J. M. Grimes, and G. L. Smith Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein J. Gen. Virol., June 1, 2007; 88(6): 1656 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Esteban and R. M. L. Buller Ectromelia virus: the causative agent of mousepox J. Gen. Virol., October 1, 2005; 86(10): 2645 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Maloney, M. Schroder, and A. G. Bowie Vaccinia Virus Protein A52R Activates p38 Mitogen-activated Protein Kinase and Potentiates Lipopolysaccharide-induced Interleukin-10 J. Biol. Chem., September 2, 2005; 280(35): 30838 - 30844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Shaw, W. B. Cardenas, D. Zamarin, P. Palese, and C. F. Basler Nuclear Localization of the Nipah Virus W Protein Allows for Inhibition of both Virus- and Toll-Like Receptor 3-Triggered Signaling Pathways J. Virol., May 15, 2005; 79(10): 6078 - 6088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stack, I. R. Haga, M. Schroder, N. W. Bartlett, G. Maloney, P. C. Reading, K. A. Fitzgerald, G. L. Smith, and A. G. Bowie Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence J. Exp. Med., March 21, 2005; 201(6): 1007 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. DiPerna, J. Stack, A. G. Bowie, A. Boyd, G. Kotwal, Z. Zhang, S. Arvikar, E. Latz, K. A. Fitzgerald, and W. L. Marshall Poxvirus Protein N1L Targets the I-{kappa}B Kinase Complex, Inhibits Signaling to NF-{kappa}B by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-{kappa}B and IRF3 Signaling by Toll-like Receptors J. Biol. Chem., August 27, 2004; 279(35): 36570 - 36578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Bartlett, L. Dumoutier, J.-C. Renauld, S. V. Kotenko, C. E. McVey, H.-J. Lee, and G. L. Smith A new member of the interleukin 10-related cytokine family encoded by a poxvirus J. Gen. Virol., June 1, 2004; 85(6): 1401 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gubser, S. Hue, P. Kellam, and G. L. Smith Poxvirus genomes: a phylogenetic analysis J. Gen. Virol., January 1, 2004; 85(1): 105 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Najarro, H.-J. Lee, J. Fox, J. Pease, and G. L. Smith Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1 J. Gen. Virol., December 1, 2003; 84(12): 3325 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pires de Miranda, P. C. Reading, D. C. Tscharke, B. J. Murphy, and G. L. Smith The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model J. Gen. Virol., September 1, 2003; 84(9): 2459 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Symons, E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model J. Gen. Virol., November 1, 2002; 83(11): 2833 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Tscharke, P. C. Reading, and G. L. Smith Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes J. Gen. Virol., August 1, 2002; 83(8): 1977 - 1986. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
